Clinical Efficacy of Pentoxifylline Combined with Thioctic Acid in the Treatment of Painful Diabetic Peripheral Neuropathy  

作　　者：Dengjuan Ma Shilong Zhang Peng Yao 

机构地区：[1]The Second People’s Hospital of Qingyang City,Qingyang 745000,Gansu Province,China

出　　处：《Journal of Clinical and Nursing Research》2024年第7期123-127,共5页临床护理研究（英文）

摘　　要：Objective:To observe the efficacy of pentoxifylline+thioctic acid in the treatment of patients with painful diabetic peripheral neuropathy(PDPN).Methods:70 patients with PDPN admitted from October 2019 to October 2022 were selected and randomly grouped,with pentoxifylline+thioctic acid treatment in Group A and thioctic acid treatment in Group B,and the treatment efficacy was compared.Results:The treatment efficacy in Group A was higher than that of Group B,P<0.05;the points of each symptom of PDPN in Group A were lower than that of Group B,P<0.05;the C-reactive protein and electromyography indexes of PDPN patients in Group A were better than that of Group B,P<0.05.Conclusion:PDPN patients treated with pentoxifylline+thioctic acid can optimize nerve function,inhibit inflammation progression,and reduce PDPN symptoms,which is an efficient and feasible treatment option.

关 键 词：Thioctic acid PENTOXIFYLLINE Painful diabetic peripheral neuropathy EFFICACY 

分 类 号：R73[医药卫生—肿瘤]